James Sapirstein is the President, Chairman, and CEO of First Wave BioPharma, a biotechnology company focused on gastrointestinal and inflammatory disease.
James Sapirstein is the President, Chairman, and CEO of First Wave BioPharma, a biotechnology company focused on gastrointestinal and inflammatory disease therapeutics. He has discussed the company’s clinical development plans, including FDA interactions and advancing programs through later-stage trials.
Full founder directory · Investor directory · Company funding database · Fundraising library